ACCENT I
ACCENT I
A Crohn’s Disease Clinical Trial Evaluating Ifliximab in a New Long-Term Treatment Regimen. A trial assessing the efficacy of immunosuppression (infliximab) in managing Crohn’s disease.Conclusion Infliximab may improve symptoms of Crohn’s disease.